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Endocardial lesions are caused not only by inflammatory processes but also by myocardial
ischemia, resulting in endocardial thrombosis and cerebral embolism. We deviced a method
for direct visualization of endocardial damages by a novel dye image cardioscopy with
Evans blue and examined its feasibility in patients with heart disease. The dye was injected
into the left ventricle before and after endomyocardial biopsy. Endocardial surface was
stained in dark blue in 63% of patients with angina pectoris before biopsy. After biopsy,
the biopsied portions were stained in blue in all. The results indicate that endocardium is
damaged even in apparently intact LV in patients with ischemic heart disease and that
endomyocardial biopsy causes severe endocardial damages.
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INTRODUCTION
In 1976, Uchida reported a original percutaneous
cardioscopic technique, and the clinical applica-
tion of the cardioscopy was started in 1987. Since
then, percutaneous cardioscopy enabled percuta-
neous observation of the interior of the heart
for a macroscopic pathologic diagnosis of the
heart disease [1-3]. Clinically, there is a specific
syndrome "Cardiocerebral Syndrome" in which
cerebral attack occures following cardiac attack
(acute myocardial infarction). It is generally
believed that thrombus formed in the heart is
detached and flows into the cerebral arteries,
resulting in this syndrome. However, the pro-
cess of thrombus formation on the endocardium
of the ischemic region of the heart is not well
known.
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Extensive myocardial infarction causes left ven-
tricular contraction disturbance and stagnation of
blood. This stagnation is believed to be the main
cause of thrombus formation. Recent cardioscopic
examination revealed frequent mural thrombus in
the left ventricle without obvious contraction dis-
turbance [4]. This fact suggests that blood stagna-
tion is not the sole cause of thrombus formation.
There is a possibility that endocardial cells which
act against thrombus formation are damaged
due to myocardial ischemia resulting in thrombus
formation. Therefore, we attempted whether or
not endocardial damages exist in patients with
ischemic heart disease.
Discrimination of endocardial cell damages are
beyond conventional cardioscopes. We found that
Evans blue dye which selectively stains endothelial
cells of the cardiovascular systems. Therefore, we




The cardioscope system was composed of a thin
5F fiberscope (Olympus Co, LTD, Tokyo, Japan)
and a 9F guiding balloon catheter (Fig. 1).
The fiberscope was connected to a CCD camera
and an illumination source (Xenon lamp). The
obtained images were displayed through a video
converter simultaneously with X-ray images on
a 14-inch video monitor and were recorded on a
vide tape.
Subjects
Thirty-five patients with heart disease (16 pts
with angina pectoris (AP), 11 with dilated cardio-
myopathy (DCM) and 8 pts with chest pain syn-
drome (CPS)) underwent percutaneous dye image
FIGURE Cardioscope used in this study. (A) fiberscope 5F (Olympus Co. Ltd., Tokyo, Japan) (B) balloon (C) shaft.DYE IMAGE CARDIOSCOPY 31
cardioscopy after the routine cardiac catheteriza-
tion. Because of the experimental nature, informed
consent for percutaneous dye image cardioscopy
was obtained from all patients.
Procedures
After the routine catheterization and angiogra-
phy, a guiding balloon catheter was introduced,
through the sheath previously introduced into the
right femoral artery, into the left ventricle. The
balloon was inflated with CO2. Then, a 5F fiber-
scope was introduced through the catheter so as to
locate its tip at the distal most tip of catheter. The
inflated balloon was pushed against the left ven-
tricular wall. Heparinized saline was infused at a
rate of 3-5 ml/sec for several seconds by a power
injector for observation. Thereafter, ml of Evans
blue dye solution (20mg/ml saline solution) was
directly injected through the guiding catheter into
the left ventricle.
RESULTS
Figure 2 shows the endocardial surface in a patient
with angina pectoris. The surface was apparently
intact before staining. After staining, however, the
surface was stained in dark blue.
Figure 3 shows the edges of the trabeculae in a
patient with angina pectoris. The edges were white
in color before staining. After staining, the edges
were stained in dark blue.
Figure 4 shows the edges of the trabeculae in
a patient with dilated cardiomyopathy. The edges
of trabeculae were atrophic and yellow in color
before biopsy. After biopsy, the biopsied portion
was extensively stained in dark blue.
FIGURE 2 47-year-old female with angina pectoris. (A) The endocardial surface was brown in color before staining. (B) The
surface was stained in dark blue with Evans blue.32 M. KANAI et al.
FIGURE 3 69-year-old male with angina pectoris. (A) The edge of trabecle was white in color before staining. (B) The endocardial
surface was stained in dark blue with Evans blue.
TABLE Endocardial staining with evans blue dye
Before biopsy After biopsy
AP 10/16 (63%) 4/4 (100%)
DCM 8/11 (73%) 6/6 (100%)
C’S 3/8 (38%) / (00%)
AP: angina pectoris, DCM: Dilated cardiomyopathy. CPS:
Chest pain syndrome.
Thus, endocardium was stained in 63% of
patients with angina pectoris. Especially, the edges
of the trabeculae were strongly stained. After
biopsy, the biopsied portions were extensively
stained (Table I).
FIGURE 4 44-year-old male with dilated cardiomyopathy.
(A) The trabecle (arrow) was atrophic and yellow in color
before biopsy. (B) The endocardium and thrombus (arrow)
were stained in dark blue after biopsy.
DISCUSSION
Recent advances in fiberscope and guiding system
technology enabled us to perform a percutaneous
observation of the luminal changes of the cardio-
vascular systems [5-8]. However, the conventional
cardioscope could not allow discrimination of fine
composition of the target. It was beyond the abil-
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of the cardiovascular changes of cellular order.
Therefore, to observe vascular luminal changes
of cellular order, an intravascular microscope
was devised, and its feasibility was examined. The
luminal changes observed by the microscope
correlated well with histologic changes [9-10].
Furthermore, structures of human vascular lesions
of cellular order could be observed percutaneously
by the intravascular microscope [11].
However, the microscope is composed of a rigid
rod lens but not of flexible thin glass fibers, and its
length is short. Therefore application to the heart
is impossible. In this study, in order to discriminate
endocardial changes of cellular order, we devised
percutaneous dye imaged cardioscopy. With the
aid of Evans blue, endocardial damages were
clearly demonstrated.
In this study, endocardial damages were fre-
quently observed in patients with angina pectoris
as in case of DCM. Inflammatory process is con-
sidered to be involved in DCM. In case of angina
pectoris, severe ischemia may affected not only
myocardial cells but also endocardial cells, leading
to their death and fibrosis. These otherwise not
demonstrable endocardial damages may contri-
bute to mural thrombus formation, which was
not infrequently observed in this category of heart
disease. These thrombus may participate in cause-
unknown cerebral thrombo-embolic attacks.
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